Drugs / Elzasonan
Elzasonan
also known as
CP-448,187 · CP-448,187-01 · CP-448,187-10 · ELZASONAN CITRATE · Elzasonan hcl · ELZASONAN HYDROCHLORIDE
Small molecule targets HTR1B, HTR1D via inhibition
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00275197 | Dec 2005 → Jul 2007 | major depressive disorder | Pfizer | Completed | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Elzasonan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00275197 ↗ |
| Known as | CP-448,187 | “Co- Administration of Sertraline And Elzasonan (CP-448,187)” NCT00275197 ↗ |
| Known as | CP-448,187-01 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3185463 ↗ |
| Known as | CP-448,187-10 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3185463 ↗ |
| Known as | ELZASONAN CITRATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL3185463 ↗ |
| Known as | Elzasonan hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL3185463 ↗ |
| Known as | ELZASONAN HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL3185463 ↗ |
| Action | Inhibit | “Serotonin 1d (5-HT1d) receptor antagonist” CHEMBL3185463 ↗1“Serotonin 1b (5-HT1b) receptor antagonist” CHEMBL3185463 ↗ |
| Modality | Small molecule | — CHEMBL3185463 ↗ |
| Target | HTR1B | “Serotonin 1b (5-HT1b) receptor antagonist” CHEMBL3185463 ↗ |
| Target | HTR1D | “Serotonin 1d (5-HT1d) receptor antagonist” CHEMBL3185463 ↗ |